期刊文献+

依托泊苷亚微乳注射液制备方法的考察 被引量:1

A Study on Preparation of Etoposide-loaded Submicro-emulsion
下载PDF
导出
摘要 目的探讨依托泊苷亚微乳注射液处方成分配比及制备工艺。方法以依托泊苷亚微乳注射液的粒径与分布、包封率及外观稳定性为评价指标,对其制备过程中的影响因素及处方成分配比等进行考察。结果依托泊苷亚微乳注射液pH在4.0~6.5之间,高压均质操作在25℃下进行,均质压力为800bar,均质6~10次可以得到粒径200nm以下且分布较均匀的亚微乳注射液。结论该法制备的依托泊苷亚微乳注射液性质稳定,方法可行。 Objective To determine the etoposide-loaded submicro-emulsion formulation and preparation process.Methods The stability of etoposide-loaded submicro-emulsion was used as the main evaluation index,and the main technological factors and formulation factors during the preparation of etoposide-loaded submicro-emulsion were studied.Results A diameter of about 200 nm and more even distribution of etoposide-loaded submicro-emulsion were obtained under the following condition:the pH value was 4.0-6.5;homogenization cycle was 6-10 times at a homogenization pressure of 800 bar at temperature of 25℃.Conclusion This method is feasible.
出处 《解放军药学学报》 CAS 2010年第4期297-300,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 依托泊苷 亚微乳注射液 工艺 处方 etoposide submicro-emulsion preparation formulation
  • 相关文献

参考文献4

  • 1Shah JC,Chen JR.Preformulation study of etoposide:identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide[J].Pharm Res,1989,6(5):408-412.
  • 2田玲玲,唐星,何海冰,王静.依托泊苷静脉注射亚微乳的制备及其体内外评价[J].药学学报,2007,42(8):892-897. 被引量:16
  • 3上海医药工业研究院药物制剂研究室编著.药用辅料应用技术(第2版)[M].北京:中国医药科技出版社,2002.298-303.
  • 4Tian L,He H,Tang X.Stability and degradation kinetics of etoposide-loaded parenteral lipid emulsion[J].J Pharm Sci,2007,96(7):1719-1728.

二级参考文献16

  • 1董世波,郑俊民.静注安定亚微乳的制备及其特征[J].中国医药工业杂志,1993,24(7):300-303. 被引量:3
  • 2秦凌浩,唐星.注射用克拉霉素乳剂的制备及其体内外评价[J].药学学报,2006,41(10):945-949. 被引量:6
  • 3Beijnen JH,Holthuis JJM,Kerkdijk HG,et al.Degradation kinetics of etoposide in aqueous solution[J].Ind J Pharm Sci,1988,41:169-178.
  • 4Smit EF,Carney DN,Harford P,et al.Phase Ⅱ study of oral etoposide in elderly patients with small cell lung cancer[J].Thorax,1989,44:257-263.
  • 5Hande KR.Etoposide:four decades of development of a topoisomerase Ⅱ inhibitor[J].Eur J Cancer,1998,34:1514-1521.
  • 6Sinkule JA.Etoposide:a semisynthetic epipodophyllotoxin.Chemistry,pharmacology,pharmacokinetics,adverse effects and use as an antineoplastic agent[J].Pharmacotherapy,1984,4:61-73.
  • 7Shah JC,Chen JR,Chow D.Preformulation study of etoposide:identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide[J].Pharm Res,1989,6:408-412.
  • 8Venkateswarlu V,Patlolla RR.Lipid microspheres as drug delivery systems[J].Ind J Pharm Sci,2001,63:450-458.
  • 9Müller RH,Schmidt S,Buttle I,et al.SolEmuls(R)-novel technology for the formulation of I.v.emulsions with poorly soluble drugs[J].Ind J Pharm Sci,2004,269:293-302.
  • 10Patlolla RR,Vobalaboina V.Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion[J].J Pharm Sci,2005,94:437-445.

共引文献15

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部